NVS - Novartis AG ADR - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

NVS is currently covered by 9 analysts with an average price target of $137.22. This is a potential upside of $16.02 (13.22%) from yesterday's end of day stock price of $121.2.

Novartis AG ADR's activity chart (see below) currently has 119 price targets and 97 ratings on display. The stock rating distribution of NVS is 35% BUY, 10% SELL and 55% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 87.72% with an average time for these price targets to be met of 567.53 days.

Highest price target for NVS is $120, Lowest price target is $120, average price target is $104.02.

Most recent stock forecast was given by ETZER DAROUT from BMO on 30-Oct-2024. First documented stock forecast 15-Jan-2016.

Split History since 2000:

4/9/19 1116 for 1000

5/11/00 2 for 1

Currently out of the existing stock ratings of NVS, 7 are a BUY (35%), 2 are a SELL (10%), 11 are a HOLD (55%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Hold

$120

$4.08 (3.52%)

$118

9 months 15 days ago
(30-Oct-2024)

4/4 (100%)

$10.09 (9.18%)

139

Hold

$122.5

11 months 11 days ago
(03-Sep-2024)

8/8 (100%)

$16.06 (15.09%)

398

Hold

$95.34

1 years 3 months 21 days ago
(24-Apr-2024)

13/13 (100%)

$2.73 (2.95%)

580

$109

$-6.92 (-5.97%)

$114

1 years 5 months 29 days ago
(16-Feb-2024)

15/15 (100%)

$12.5 (12.95%)

892

Sell

$90.02

$-25.9 (-22.34%)

$100.71

1 years 9 months 22 days ago
(23-Oct-2023)

4/4 (100%)

$-1.19 (-1.30%)

161

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is NVS (Novartis AG ADR) average time for price targets to be met?

On average it took 567.53 days on average for the stock forecasts to be realized with a an average price target met ratio 87.72

Which analyst has the current highest performing score on NVS (Novartis AG ADR) with a proven track record?

SEAMUS FERNANDEZ

Which analyst has the most public recommendations on NVS (Novartis AG ADR)?

Seamus Fernandez works at GUGGENHEIM and has 7 price targets and 6 ratings on NVS

Which analyst is the currently most bullish on NVS (Novartis AG ADR)?

Eric Le Berrigaud with highest potential upside - $21.14

Which analyst is the currently most reserved on NVS (Novartis AG ADR)?

Kerry Holford with lowest potential downside - -$37.79

Novartis AG ADR in the News

Chronic Obstructive Pulmonary Disease Treatment Devices Market Insights, Competitive Landscape, and Market Forecast 2024-2032

Company Logo The Chronic Obstructive Pulmonary Disease (COPD) Treatment Devices Market is set to grow at a CAGR of 6.35% from 2025 to 2032. This surge is driven by rising COPD prevalence due to factors like tobacco smoking and air pollution, increased awareness, early diagnosis, and innovative product development. Key devices include inhalers and nebulizers....

Vaisala Oyj: Omien osakkeiden hankinta 7.8.2025

VAISALA OYJPÖRSSITIEDOTE 7.8.2025 Vaisala Oyj: Omien osakkeiden hankinta 7.8.2025 Helsingin Pörssi Päivämäärä7.8.2025 PörssikauppaOsto OsakelajiVAIAS Osakemäärä2 000osaketta Keskihinta/ osake 46,7738EUR Kokonaishinta93 547,60EUR Yhtiön hallussa olevat omat osakkeet 7.8.2025 tehtyjen kauppojen jälkeen: 133 629 kpl. Omia osakkeita hankitaan markkinoiden väärinkäyttöasetuksen (EU) N:o 596/2014 5 artiklan sekä Euroopan komission delegoidun asetuksen (EU) 2016/1052 mukaisesti. Vaisala Oyj:n puolesta Nordea...
Show more

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?